PFU Therapeutics

PFU Therapeutics has developed a 'next-generation' RNA targeting technology. With their 'fail-fast' approach to medicine development coupled with their 'patient-centricity', PFU Therapeutics are developing programs to address rare diseases with unmet clinical needs.